Lonza

Matthew Hewitt, Ph.D., Head of Clinical Development
Basel, Switzerland
(OTCMKTS: LZAGY)
In Lonza Pharma, Biotech & Nutrition, we work to improve health by supporting our customers to deliver innovative solutions to prevent, treat or even cure disease. The segment provides a wide range of services and products from early phase discovery to custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries. Our extensive track record includes commercialization of pioneering therapies and manufacturing of a wide variety of biological and chemical drugs. We continuously invest to solve not just the current, but also the future challenges. Together, let’s bring your next medicine to life. www.lonza.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions